Literature DB >> 24965670

Editorial: Balancing tumor necrosis factor receptor I and tumor necrosis factor receptor II jointly for joint inflammation.

Bharat B Aggarwal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24965670     DOI： 10.1002/art.38753

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  8 in total

1.  Does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis?: Comment on Olson et al.: "Therapeutic Opportunities to Prevent Post-Traumatic Arthritis: Lessons From the Natural History of Arthritis After Articular Fracture".

Authors:  Jian-Lu Wei; John Buza; Chuan-Ju Liu
Journal:  J Orthop Res       Date:  2015-12-08       Impact factor: 3.494

2.  Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1.

Authors:  Sophie Steeland; Leen Puimège; Roosmarijn E Vandenbroucke; Filip Van Hauwermeiren; Jurgen Haustraete; Nick Devoogdt; Paco Hulpiau; Geert Leroux-Roels; Debby Laukens; Philip Meuleman; Martine De Vos; Claude Libert
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

3.  Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension.

Authors:  Laura J Goodall; Milan Ovecka; Daniel Rycroft; Sarah L Friel; Andrew Sanderson; Prafull Mistry; Marie L Davies; A Allart Stoop
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

Review 4.  New discovery rarely runs smooth: an update on progranulin/TNFR interactions.

Authors:  Betty C Wang; Helen Liu; Ankoor Talwar; Jinlong Jian
Journal:  Protein Cell       Date:  2015-09-25       Impact factor: 14.870

5.  TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis.

Authors:  Xin Chen; Yingjie Nie; Haitao Xiao; Zhaoxiang Bian; Anthony J Scarzello; Na-Young Song; Anna L Trivett; Joost J Oppenheim
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

Review 6.  Review: Novel Insights Into Tumor Necrosis Factor Receptor, Death Receptor 3, and Progranulin Pathways in Arthritis and Bone Remodeling.

Authors:  Anwen Williams; Eddie C Y Wang; Lorenz Thurner; Chuan-Ju Liu
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

Review 7.  A New Venue of TNF Targeting.

Authors:  Sophie Steeland; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Int J Mol Sci       Date:  2018-05-11       Impact factor: 5.923

8.  TNFR1 inhibition with a Nanobody protects against EAE development in mice.

Authors:  Sophie Steeland; Sara Van Ryckeghem; Griet Van Imschoot; Riet De Rycke; Wendy Toussaint; Leen Vanhoutte; Christian Vanhove; Filip De Vos; Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.